SEROPREVALENCE OF HIV, HEPATITIS B, AND HEPATITIS C AMONG OPIOID DRUG USERS ON METHADONE TREATMENT IN THE NETHERLANDS
Spremljeno u:
SCHREUDER, I., ET AL., SEROPREVALENCE OF HIV, HEPATITIS B, AND HEPATITIS C AMONG OPIOID DRUG USERS ON METHADONE TREATMENT IN THE NETHERLANDS. HARM REDUCTION JOURNAL, Vol. 7 (2010), 7 p.
Ref.
173404
Lokacija:
SIIS R.1830 Archivo
Palabras clave:
Alto riesgo, Drogodependencias, Factor de protección, Hepatitis, Metadona, Opiáceos, Programas de mantenimiento, Sida, Tratamiento médico, Vía intravenosa, Países Bajos
Alto riesgo, Drogodependencias, Factor de protección, Hepatitis, Metadona, Opiáceos, Programas de mantenimiento, Sida, Tratamiento médico, Vía intravenosa, Países Bajos
Slični predmeti: SEROPREVALENCE OF HIV, HEPATITIS B, AND HEPATITIS C AMONG OPIOID DRUG USERS ON METHADONE TREATMENT IN THE NETHERLANDS
- SEROPREVALENCE OF HEPATITIS A, B, C, AND D MARKERS AND LIVER FUNCTION ABNORMALITIES IN INTRAVENOUS HEROIN ADDICTS
- MULTIPLE RISKS FOR HIV AND HEPATITIS B INFECTION AMONG HEROIN USERS
- OPTIMAL TARGETING OF HEPATITIS C VIRUS TREATMENT AMONG INJECTING DRUG USERS TO THOSE NOT ENROLLED IN METHADONE MAINTENANCE PROGRAMS
- THE AUSTRALIAN STUDY OF HIV AND INJECTING DRUG USE. PART I: PREVALENCE FOR HIV, HEPATITIS B AND HEPATITIS C AMONG INJECTING DRUG USERS IN FOUR AUSTRALIAN CITIES
- HEALTH RELATED QUALITY OF LIFE IN METHADONE MAINTENANCE PATIENTS WITH UNTREATED HEPATITIS C VIRUS INFECTION
- SPECIAL REPORT: HIV-HEPATITIS C